All Updates

All Updates

icon
Filter
Partnerships
BioAro and GeneOnline partner to advance genetic testing and analysis in the Asia-Pacific region
Precision Medicine
Aug 14, 2024
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Today
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Today
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Today
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Today
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Today
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Yesterday
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Yesterday
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Yesterday
Partnerships
FinFit partners with Sunny Day Fund to offer emergency savings accounts
Financial Wellness Tools
Yesterday
Partnerships
KSP partners with Peak Technologies and Locus Robotics for warehouse automation
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Aug 14, 2024

BioAro and GeneOnline partner to advance genetic testing and analysis in the Asia-Pacific region

Partnerships

  • BioAro has partnered with GeneOnline to enhance genetic testing and data analysis across the Asia-Pacific region. The other terms of the partnership were undisclosed.

  • The collaboration aims to standardize and speed up genetic testing processes, allowing patients to receive more accurate and rapid results. By employing BioAro's PanOmiQ technology for real-time genomics solutions and GeneOnline's market access and strategic connections within Asia, the partnership expects to introduce innovative technologies in genetic testing and drive market growth.

  • Analyst QuickTake: The PanOmicQ platform was launched globally in May 2024 , during the Precision Medicine Expo at the Dubai World Trade Center. With capabilities such as microbial community analysis (metagenomics), pharmacogenomics, and multi-omics analysis, it is designed to identify biomarkers affected by lifestyle, medications, and environment, aiding personalized interventions for complex disorders.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.